NOTE 9 – FAIR VALUE MEASUREMENTS

The Company did not have any financial assets measured at fair value on a recurring basis. The following tables summarize our fair value hierarchy for our financial liabilities measured at fair value on a recurring basis as of December 31, 2025 and 2024.

 

 

 

Fair Value at December 31,

 

 

 

Level

 

2025

 

 

2024

 

Liabilities

 

 

 

 

 

 

 

 

Litigation financing

 

3

 

$

63,287,048

 

 

$

56,950,377

 

2022 Warrants

 

3

 

 

7,833,301

 

 

 

2,060,773

 

March 2023 Warrants

 

3

 

 

2,217,838

 

 

 

1,910,950

 

December 2023 Warrants

 

3

 

 

2,099,221

 

 

 

827,036

 

March 2023 Note Conversion Option

 

3

 

 

 

 

 

2,745,000

 

December 2023 Note Conversion Option

 

3

 

 

 

 

 

307,000

 

Total of fair valued liabilities

 

 

 

$

75,437,408

 

 

$

64,801,136

 

 

The Litigation financing valuation was based on the following assumptions: amounts funded by the Funder, the corresponding IRR calculation, percentage applicable to the recovery percentage calculation and management’s good-faith estimates for estimated outcome probabilities and estimated debt repayment dates.

The 2022 Warrants, the March 2023 Warrants and the December 2023 Warrants are measured using a Black-Scholes valuation model. The assumptions used in this model included the use of key inputs, including expected stock volatility, the risk–free interest rate, the expected life of the warrants and the expected dividend yield. Expected volatility is calculated based on the historical volatility of our Common Stock over the term of the warrant. Risk–free interest rates are calculated based on risk–free rates for the appropriate term. The expected life is estimated based on contractual terms and the remaining term to maturity. The dividend yield is based on the historical dividends issued by the Company. If the volatility rate or risk-free interest rate were to change, the value of the warrants would be impacted.

As of December 31, 2024, the embedded derivatives for the conversion options on the March 2023 Notes and December 2023 Notes are measured at fair value, Level 3, using the with-and-without valuation method. The assumptions used in this model included

key inputs, including expected stock volatility, the risk–free interest rate, the expected life of the option, the expected dividend yield, and the appropriate discount rate. Expected volatility is calculated based on the historical volatility of our Common Stock over the term of the notes. Risk–free interest rates are calculated based on risk–free rates for the appropriate term. The expected life is estimated based on contractual terms. The dividend yield is based on the historical dividends issued by the Company. The discount rate is derived based on a risk-adjusted market rate for CCC-rated corporate bond yields. If the volatility rate or risk-free interest rate were to change, the value of the notes would be impacted.

Items not included in the above disclosures include cash and cash equivalents, accounts and other related party receivables, other current assets and accounts payable. The carrying values of those items, as reflected in the consolidated balance sheets, approximate their fair value at December 31, 2025 and 2024. The fair value of assets and liabilities whose carrying value approximates fair value is determined using Level 2 inputs, with the exception of cash and cash equivalents, which is determined using Level 1.

Changes in our Level 3 fair value measurements were as follows:

 

 

37N Note
Conversion Option

 

 

March 2023
Warrants

 

 

December 2023
Warrants

 

 

Put option
liability

 

 

March 2023
Conversion Option

 

 

December 2023
Conversion Option

 

 

Litigation
financing

 

 

2022 Warrants

 

 

Total

 

Balance as of December 31, 2023

 

$

702,291

 

 

$

 

 

$

2,392,563

 

 

$

5,637,162

 

 

$

 

 

$

 

 

$

52,115,647

 

 

$

13,399,822

 

 

$

74,247,485

 

Debt conversion to equity

 

 

(341,601

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(341,601

)

Added conversion option (embedded derivative)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

690,000

 

 

 

161,000

 

 

 

 

 

 

 

 

 

851,000

 

Classification of warrants as liability

 

 

 

 

 

7,754,438

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7,754,438

 

Warrant repricing (Note 8)

 

 

 

 

 

808,508

 

 

 

348,168

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1,156,676

 

Change in fair value

 

 

(360,690

)

 

 

(6,651,996

)

 

 

(1,913,695

)

 

 

(5,637,162

)

 

 

2,055,000

 

 

 

146,000

 

 

 

4,834,730

 

 

 

(11,339,049

)

 

 

(18,866,862

)

Balance as of December 31, 2024

 

$

 

 

$

1,910,950

 

 

$

827,036

 

 

$

 

 

$

2,745,000

 

 

$

307,000

 

 

$

56,950,377

 

 

$

2,060,773

 

 

$

64,801,136

 

Debt conversion to equity

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(9,020,436

)

 

 

(5,373,605

)

 

 

 

 

 

 

 

 

(14,394,041

)

Warrants exercised

 

 

 

 

 

(2,888,830

)

 

 

(404,504

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(3,293,334

)

Issuance of new funding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

110,005

 

 

 

 

 

 

110,005

 

Change in fair value

 

 

 

 

 

3,195,718

 

 

 

1,676,689

 

 

 

 

 

 

6,275,436

 

 

 

5,066,605

 

 

 

6,226,666

 

 

 

5,772,528

 

 

 

28,213,642

 

Balance as of December 31, 2025

 

$

 

 

$

2,217,838

 

 

$

2,099,221

 

 

$

 

 

$

 

 

$

 

 

$

63,287,048

 

 

$

7,833,301

 

 

$

75,437,408

 

 

Additional information about the litigation financing liability and embedded derivative liability related to the March 2023 Notes and December 2023 Notes is included in Note 10 – Derivative Financial Instruments.

The consolidated financial statements include an out-of-period adjustment of $8.5 million for the three and nine months ended September 30, 2025, related to the change in the fair value of the March 2023 Notes and December 2023 Notes derivative liability and additional paid-in capital to correct for an error identified during the preparation of the financial statements for the year ended December 31, 2025. The Company has determined that this error was not material to the historical financial statements in any individual period or in the aggregate and did not result in the previously issued financial statements being materially misstated.

Historical Timeline

Fiscal YearFiled
2025Mar 31, 2026Showing above
2024Mar 31, 2025
2023May 17, 2024

About Fair Value Disclosures

Fair value disclosures classify all assets and liabilities measured at fair value into a three-level hierarchy: Level 1 (quoted market prices), Level 2 (observable inputs like yield curves), and Level 3 (unobservable inputs requiring management estimates). The proportion of Level 3 assets directly reflects how much of the balance sheet depends on internal models rather than market evidence.

Key signals: a growing Level 3 balance relative to total fair-value assets increases valuation uncertainty and earnings volatility risk. Watch for transfers between levels — assets moving from Level 2 to Level 3 often signal deteriorating market liquidity. Unrealized gains and losses on Level 3 positions flow through earnings or other comprehensive income, so large swings deserve scrutiny. For financial institutions, examine the sensitivity disclosures that show how Level 3 valuations change under alternative assumptions. Compare the fair value of debt against its carrying amount to gauge hidden leverage.